Hanmi Pharm. Co., Ltd.

KOSE:A128940 株式レポート

時価総額：₩3.6t

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Hanmi Pharm マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Jae-Hyun Park

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間1.5yrs
CEOの所有権0.005%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Hanmi Pharm (KRX:128940) Seems To Use Debt Rather Sparingly

Jun 11
Hanmi Pharm (KRX:128940) Seems To Use Debt Rather Sparingly

A Look At The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)

May 08
A Look At The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm. Co., Ltd.'s (KRX:128940) Share Price Not Quite Adding Up

Apr 22
Hanmi Pharm. Co., Ltd.'s (KRX:128940) Share Price Not Quite Adding Up

Calculating The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)

Mar 15
Calculating The Intrinsic Value Of Hanmi Pharm. Co., Ltd. (KRX:128940)

Hanmi Pharm (KRX:128940) Use Of Debt Could Be Considered Risky

Feb 16
Hanmi Pharm (KRX:128940) Use Of Debt Could Be Considered Risky

What Percentage Of Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Do Insiders Own?

Jan 17
What Percentage Of Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Do Insiders Own?

Hanmi Pharm's (KRX:128940) Stock Price Has Reduced 48% In The Past Five Years

Dec 22
Hanmi Pharm's (KRX:128940) Stock Price Has Reduced 48% In The Past Five Years

Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Could Be 22% Below Their Intrinsic Value Estimate

Nov 24
Hanmi Pharm. Co., Ltd. (KRX:128940) Shares Could Be 22% Below Their Intrinsic Value Estimate

CEO（最高経営責任者

Jae-Hyun Park (56 yo)

1.5yrs

在職期間

Mr. Jae-Hyun Park serves as Head of Quality Management Team of Hanmi Pharmaceutical Co., Ltd. He is Chief Executive Officer at Hanmi Pharm. Co., Ltd since 2023.Mr. Park serves as a Director of Paik Kwang...